Vimarsana
Biggest News Aggregation in the World

Page 3 - Bio Path News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bio Path. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bio Path Today - Breaking & Trending Today

StockNews.com Begins Coverage on Bio-Path (NASDAQ:BPTH) - Vimarsana News

StockNews.com Begins Coverage on Bio-Path (NASDAQ:BPTH)

StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a report issued on Friday. The firm issued a sell rating on the stock. Bio-Path Price Performance Shares of NASDAQ BPTH opened at $0.46 on Friday. Bio-Path has a 1 year low of $0.32 and a 1 year high of $2.35. The company’s […]

Bio-Path (NASDAQ:BPTH) Receives New Coverage from Analysts at StockNews.com - Vimarsana News

Bio-Path (NASDAQ:BPTH) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a report released on Thursday. The brokerage issued a sell rating on the stock. Bio-Path Stock Down 1.9 % Shares of Bio-Path stock opened at $0.53 on Thursday. Bio-Path has a 12 month low of $0.32 and a 12 month high of $2.35. […]

Bio-Path (NASDAQ:BPTH) Receives New Coverage from Analysts at StockNews.com - Vimarsana News

Bio-Path (NASDAQ:BPTH) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a report issued on Monday morning. The firm issued a sell rating on the stock. Bio-Path Price Performance Shares of NASDAQ:BPTH opened at $0.63 on Monday. The business’s fifty day moving average price is $0.43 and its two-hundred day moving average price is […]

Bio-Path (NASDAQ:BPTH) Earns Sell Rating from Analysts at StockNews.com - Vimarsana News

Bio-Path (NASDAQ:BPTH) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research report released on Monday morning. The firm issued a sell rating on the stock. Bio-Path Stock Performance BPTH opened at $0.63 on Monday. The stock has a market capitalization of $7.18 million, a PE ratio of -0.28 and a beta of […]

Source: wkrb13.com
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Short Interest Up 66.9% in October - Vimarsana News

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Short Interest Up 66.9% in October

Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) was the recipient of a large increase in short interest during the month of October. As of October 15th, there was short interest totalling 284,900 shares, an increase of 66.9% from the September 30th total of 170,700 shares. Based on an average daily trading volume, of 2,870,000 […]